These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29302068)

  • 1. Autoimmunity checkpoints as therapeutic targets in B cell malignancies.
    Müschen M
    Nat Rev Cancer; 2018 Feb; 18(2):103-116. PubMed ID: 29302068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.
    Chen Z; Shojaee S; Buchner M; Geng H; Lee JW; Klemm L; Titz B; Graeber TG; Park E; Tan YX; Satterthwaite A; Paietta E; Hunger SP; Willman CL; Melnick A; Loh ML; Jung JU; Coligan JE; Bolland S; Mak TW; Limnander A; Jumaa H; Reth M; Weiss A; Lowell CA; Müschen M
    Nature; 2015 May; 521(7552):357-61. PubMed ID: 25799995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell receptor signaling in lymphoid malignancies and autoimmunity.
    Avalos AM; Meyer-Wentrup F; Ploegh HL
    Adv Immunol; 2014; 123():1-49. PubMed ID: 24840946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS primary central nervous system lymphoma: molecular analysis of the expressed VH genes and possible implications for lymphomagenesis.
    Julien S; Radosavljevic M; Labouret N; Camilleri-Broet S; Davi F; Raphael M; Martin T; Pasquali JL
    J Immunol; 1999 Feb; 162(3):1551-8. PubMed ID: 9973412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface immunoglobulin-negative acute lymphoblastic leukaemia with predominant L1 morphology, occasional L3 cells and t(8;22).
    Reid MM; Drewery C; Windebank KP
    Br J Haematol; 2003 Sep; 122(5):693. PubMed ID: 12930379
    [No Abstract]   [Full Text] [Related]  

  • 6. B-cell receptor signaling in chronic lymphocytic leukemia and other B-cell malignancies.
    Koehrer S; Burger JA
    Clin Adv Hematol Oncol; 2016 Jan; 14(1):55-65. PubMed ID: 27057669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen selection in B-cell lymphomas--tracing the evidence.
    Sutton LA; Agathangelidis A; Belessi C; Darzentas N; Davi F; Ghia P; Rosenquist R; Stamatopoulos K
    Semin Cancer Biol; 2013 Dec; 23(6):399-409. PubMed ID: 23932942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
    Seda V; Mraz M
    Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia.
    Yuan N; Song L; Zhang S; Lin W; Cao Y; Xu F; Fang Y; Wang Z; Zhang H; Li X; Wang Z; Cai J; Wang J; Zhang Y; Mao X; Zhao W; Hu S; Chen S; Wang J
    Haematologica; 2015 Mar; 100(3):345-56. PubMed ID: 25512644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Bruton's tyrosine kinase in B cells and malignancies.
    Pal Singh S; Dammeijer F; Hendriks RW
    Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting B cell receptor signalling in cancer: preclinical and clinical advances.
    Burger JA; Wiestner A
    Nat Rev Cancer; 2018 Mar; 18(3):148-167. PubMed ID: 29348577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity and B-cell malignancies.
    Dighiero G
    Verh Dtsch Ges Pathol; 1996; 80():148-59. PubMed ID: 9020570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia.
    Irving JA
    Br J Haematol; 2016 Mar; 172(5):655-66. PubMed ID: 26568036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression in childhood acute lymphoblastic leukemia after remission induction therapy concerns B not T lymphocytes.
    Luczynski W; Krawczuk-Rybak M; Muszynska-Roslan K; Stasiak-Barmuta A; Zak J
    Med Pediatr Oncol; 2002 Aug; 39(2):147-8. PubMed ID: 12116070
    [No Abstract]   [Full Text] [Related]  

  • 15. The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancer.
    Coffey G; Betz A; DeGuzman F; Pak Y; Inagaki M; Baker DC; Hollenbach SJ; Pandey A; Sinha U
    J Pharmacol Exp Ther; 2014 Dec; 351(3):538-48. PubMed ID: 25253883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactivity and the positive selection of B cells.
    Übelhart R; Jumaa H
    Eur J Immunol; 2015 Nov; 45(11):2971-7. PubMed ID: 26350303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.
    Eswaran J; Sinclair P; Heidenreich O; Irving J; Russell LJ; Hall A; Calado DP; Harrison CJ; Vormoor J
    Leukemia; 2015 Aug; 29(8):1623-31. PubMed ID: 25943180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of lymphoblastic lymphoma with aberrant morphologic feature.
    Nakamura N; Tasaki K; Tominaga K; Nomizu T; Mulder AH; Abe M; Wakasa H
    Fukushima J Med Sci; 1994 Dec; 40(2):149-57. PubMed ID: 7642166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.
    Boer JM; den Boer ML
    Eur J Cancer; 2017 Sep; 82():203-218. PubMed ID: 28709134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies.
    Puri KD; Di Paolo JA; Gold MR
    Int Rev Immunol; 2013 Aug; 32(4):397-427. PubMed ID: 23886342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.